|
|
Board of DirectorsChristian Bailey, Chief Executive Officer Christian Bailey is co-founder and CEO of Ligon where he leads corporate and business development and serves on the Board of Directors. Prior to Ligon, Christian was the co-founder and CEO of multiple private companies in the technology sector. Christian is a serial entrepreneur and Managing Partner at incTANK Ventures, which has backed life sciences companies such as Agrivida and AgaMatrix. He holds a BA and MA in economics and management from Oxford University, and completed studies in molecular biology and solid state chemistry as a Fellow at MIT. Patrick Kleyn, PhD, President and Chief Scientific Officer Dr. Kleyn is a founder of Ligon. As CSO, he leads internal R&D, external collaborations, and operations. Formerly, he served as Director of Scientific Planning at the Broad Institute where he raised over $40M in research funding primarily from pharmaceutical partners. Before joining the Broad, Dr. Kleyn was Chief Scientific Officer at Gemini Genomics, where he participated in an IPO which raised $96M prior to its $238M merger with Sequenom in 2001. He was also one of the initial scientists at Millennium Pharmaceuticals where he led the cloning of an obesity gene, one of the company’s first major scientific achievements. He subsequently held multiple senior research-management positions at Millennium and Millennium Predictive Medicine. He was a Postdoctoral fellow at Columbia University, has a PhD in Genetics from the University of London (UK), and received a BA in Natural Sciences from Cambridge University (UK). |